Jasper Therapeutics’ management team is comprised of experienced biopharma industry veterans with extensive track records in drug development and commercialization. With this leadership, we are well positioned to achieve our vision of exponentially expanding the eligible patient population both for allogeneic and autologous gene edited hematopoietic stem cell therapy.
Chief Executive Officer
Chief Operating and Financial Officer
Carol Zoltowski, V.M.D.
Senior Vice President, Regulatory Affairs and Quality
Wendy Pang, M.D., Ph.D.
Senior Vice President, Research and Translational Medicine
Luca Di Noto, Ph.D.
Vice President, Technical Operations
Arjun Agarwal, CPA
Vice President, Finance and Corporate Controller
David Ku, M.D.
Vice President, Corporate Development, Portfolio Strategy & Management
Scientific Advisory Board
Jasper Therapeutics has established a premier, world-class Scientific Advisory Board of accomplished scientific leaders who are experts in immunology, blood and bone marrow transplantation, stem cell and gene therapy, and hematologic cancers.